Abstract
The schizophrenia phenotype is heterogeneous with respect to clinical presentation, long-term response to medication, and outcome, possibly reflecting genetic heterogeneity and/or the presence of modifier genes.1 Compared to non-responders, schizophrenic patients who are responders to neuroleptic medications are characterized by a high female/male ratio,2a better long-term outcome3 and more frequently disturbed dopamine neurotransmission.4 In this study, we compared two groups of schizophrenic patients selected on the basis of their long-term response to neuroleptics (excellent responders and non-responders) and a group of healthy volunteers, with regard to a missense mutation (677C→T) in the methylenetetrahydrofolate reductase (MTHFR) gene. This polymorphism was chosen because it is functional5 and was previously associated with schizophrenia.6 The present study revealed a significant association between schizophrenia and allele T of this gene. This association was entirely due to an over-representation of allele T in responder patients compared to controls; nonresponder patients did not differ from controls. Genotype TT was more frequent in responder patients compared to controls, thus replicating the findings of Arinami et al.6 These results strongly suggest that the MTHFR gene is involved in the pathogenesis of schizophrenia characterized by a rapid and sustained therapeutic response to typical neuroleptics and/or a good long-term prognosis/favorable therapeutic outcome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tsuang MT, Lyons MJ, Faraone SV . Heterogeneity of schizophrenia. Conceptual models and analytic strategies Br J Psychiatry 1990; 156: 17–26
Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S et al. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients Am J Psychiatry 1995; 152: 698–703
Breier A, Schreiber JL, Dyer J, Pickar D . National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome Arch Gen Psychiatry 1991; 48: 239–246
Tsuang MT, Lyons MJ, Faraone SV . Heterogeneity of schizophrenia. Conceptual models and analytic strategies Br J Psychiatry 1990; 156: 17–26
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase [letter] Nat Genet 1995; 10: 111–113
Arinami T, Yamada N, Yamakawa-Kobayashi K, Hamaguchi H, Toru M . Methylenetetrahydrofolate reductase variant and schizophrenia/depression Am J Med Genet 1997; 74: 526–528
Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt DS et al. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease Arterio Thromb Vasc Biol 1997; 17: 569–573
Bakker RC, Brandjes DP . Hyperhomocysteinaemia and associated disease Pharm World Sci 1997; 19: 126–132
Grandone E, Margaglione M, Colaizzo D, d'Addedda M, D'Andrea G, Pavone G et al. Methylene tetrahydrofolate reductase (MTHFR) 677T→C mutation and unexplained early pregnancy loss [letter] Thrombosis & Haemostasis 1998; 79: 1056–1057
Regland B, Johansson BV, Grenfeldt B, Hjelmgren LT, Medhus M . Homocysteinemia is a common feature of schizophrenia J Neural Transm – Gen Sect 1995; 100: 165–169
Regland B, Johansson BV, Gottfries CG . Homocysteinemia and schizophrenia as a case of methylation deficiency J Neural Transm – Gen Sect 1994; 98: 143–152
Pasquier F, Lebert F, Petit H, Zittoun J, Marquet J . Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult [letter] J Neurol Neurosurg Psychiatry 1994; 57: 765–766
Freeman JM, Finkelstein JD, Mudd SH . Folate-responsive homocystinuria and ‘schizophrenia’. A defect in methylation due to deficient 5, 10-methylenetetrahydrofolate reductase activity N Engl J Med 1975; 292: 491–496
Grieco AJ . Homocystinuria: pathogenetic mechanisms Am J Med Sci 1977; 273: 120–132
Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S . C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group Atherosclerosis 1998; 136: 347–354
Dalman C, Allebeck P, Cullberg J, Grunewald C, Koster M . Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort Arch Gen Psychiatry 1999; 56: 234–240
Wyatt RJ . Neuroleptics and the natural course of schizophrenia Schizophr Bull 1991; 17: 325–351
Joober R, Benkelfat C, Toulouse A, Lafrenière RG, Lal S, Ajroud S et al. Analysis of 14 CAG repeat-containing genes in schizophrenia Am J Med Genet 1999; 88: 694–699
Kane J, Honigfeld G, Singer J, Meltzer H . Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine Arch Gen Psychiatry 1988; 45: 789–796
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Joober, R., Benkelfat, C., Lal, S. et al. Association between the methylenetetrahydrofolate reductase 677C→T missense mutation and schizophrenia. Mol Psychiatry 5, 323–326 (2000). https://doi.org/10.1038/sj.mp.4000724
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000724
Keywords
This article is cited by
-
Association of HSPA1B genotypes with psychopathology and neurocognition in patients with the first episode of psychosis: a longitudinal 18-month follow-up study
The Pharmacogenomics Journal (2020)
-
Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis
BMC Medical Genetics (2015)
-
Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis
Journal of Neural Transmission (2015)
-
Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics
Translational Psychiatry (2012)
-
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research
Molecular Psychiatry (2007)